FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015919732> ?p ?o ?g. }

• W2015919732 endingPage "1539" @default.
• W2015919732 startingPage "1533" @default.
• W2015919732 abstract "Objective To evaluate the performance of the EuroSCORE II (ESII) and the Society of Thoracic Surgeons (STS) scores in surgical (SAVR) or transcatheter aortic valve replacement (TAVR). Design Systematic review of the literature and meta-analysis. Setting University hospitals. Participants Studies reporting data on the performance of ESII and STS scores in patients undergoing SAVR or TAVR. Interventions SAVR or TAVR. Measurements and Main Results Ten studies validated these scores in 13,856 patients who underwent either TAVR or SAVR. Operative mortality was 5.9% (SAVR 3.1%; TAVR 9.6%). ESII-expected mortality was 5.1% (O/E ratio: 1.15, SAVR, O/E ratio 0.94; TAVR, O/E ratio 1.23) and STS-expected mortality was 6.3% (O/E ratio: 0.94, SAVR, O/E ratio 0.84; TAVR, O/E ratio 1.13). The area under the ROC curve for ESII was 0.70 and for STS was 0.70 (SAVR patients: 0.73 for ESII and 0.75 for STS; TAVR patients; 0.66 for ESII and 0.63 for STS). The difference between observed/expected mortality was not significant for ESII (Peto’s OR 0.99, p = 0.88) and was significant for STS (Peto’s OR 0.86, p = 0.008). ESII (Peto’s OR 1.35, p<0.00001) and STS (Peto’s OR 1.23, p<0.00001) significantly underestimated the mortality risk in TAVR patients. The STS (Peto’s OR 0.74, p<0.0001) and, to a lesser extent, the ESII (Peto’s OR 0.86, p = 0.0.04) overestimated the mortality risk in SAVR patients. Conclusions The ESII and STS scores have good O/E ratios for either TAVR or SAVR patients, but both scores significantly underpredicted the risk of TAVR patients. ESII seemed to be accurate in predicting the risk of SAVR patients. To evaluate the performance of the EuroSCORE II (ESII) and the Society of Thoracic Surgeons (STS) scores in surgical (SAVR) or transcatheter aortic valve replacement (TAVR). Systematic review of the literature and meta-analysis. University hospitals. Studies reporting data on the performance of ESII and STS scores in patients undergoing SAVR or TAVR. SAVR or TAVR. Ten studies validated these scores in 13,856 patients who underwent either TAVR or SAVR. Operative mortality was 5.9% (SAVR 3.1%; TAVR 9.6%). ESII-expected mortality was 5.1% (O/E ratio: 1.15, SAVR, O/E ratio 0.94; TAVR, O/E ratio 1.23) and STS-expected mortality was 6.3% (O/E ratio: 0.94, SAVR, O/E ratio 0.84; TAVR, O/E ratio 1.13). The area under the ROC curve for ESII was 0.70 and for STS was 0.70 (SAVR patients: 0.73 for ESII and 0.75 for STS; TAVR patients; 0.66 for ESII and 0.63 for STS). The difference between observed/expected mortality was not significant for ESII (Peto’s OR 0.99, p = 0.88) and was significant for STS (Peto’s OR 0.86, p = 0.008). ESII (Peto’s OR 1.35, p<0.00001) and STS (Peto’s OR 1.23, p<0.00001) significantly underestimated the mortality risk in TAVR patients. The STS (Peto’s OR 0.74, p<0.0001) and, to a lesser extent, the ESII (Peto’s OR 0.86, p = 0.0.04) overestimated the mortality risk in SAVR patients. The ESII and STS scores have good O/E ratios for either TAVR or SAVR patients, but both scores significantly underpredicted the risk of TAVR patients. ESII seemed to be accurate in predicting the risk of SAVR patients." @default.
• W2015919732 created "2016-06-24" @default.
• W2015919732 creator A5014280780 @default.
• W2015919732 creator A5046691342 @default.
• W2015919732 creator A5053380260 @default.
• W2015919732 creator A5053429712 @default.
• W2015919732 creator A5060570812 @default.
• W2015919732 creator A5070682945 @default.
• W2015919732 creator A5086893879 @default.
• W2015919732 date "2014-12-01" @default.
• W2015919732 modified "2023-10-18" @default.
• W2015919732 title "Meta-analysis on the Performance of the EuroSCORE II and the Society of Thoracic Surgeons Scores in Patients Undergoing Aortic Valve Replacement" @default.
• W2015919732 cites W1496396876 @default.
• W2015919732 cites W1702536112 @default.
• W2015919732 cites W1979423827 @default.
• W2015919732 cites W2000282767 @default.
• W2015919732 cites W2005752498 @default.
• W2015919732 cites W2023215889 @default.
• W2015919732 cites W2042665434 @default.
• W2015919732 cites W2043874102 @default.
• W2015919732 cites W2058620491 @default.
• W2015919732 cites W2078814368 @default.
• W2015919732 cites W2079367512 @default.
• W2015919732 cites W2102051152 @default.
• W2015919732 cites W2114462078 @default.
• W2015919732 cites W2121947900 @default.
• W2015919732 cites W2125391094 @default.
• W2015919732 cites W2127478622 @default.
• W2015919732 cites W2153349718 @default.
• W2015919732 cites W2156452605 @default.
• W2015919732 cites W4249611253 @default.
• W2015919732 doi "https://doi.org/10.1053/j.jvca.2014.03.014" @default.
• W2015919732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25263775" @default.
• W2015919732 hasPublicationYear "2014" @default.
• W2015919732 type Work @default.
• W2015919732 sameAs 2015919732 @default.
• W2015919732 citedByCount "32" @default.
• W2015919732 countsByYear W20159197322014 @default.
• W2015919732 countsByYear W20159197322015 @default.
• W2015919732 countsByYear W20159197322016 @default.
• W2015919732 countsByYear W20159197322017 @default.
• W2015919732 countsByYear W20159197322018 @default.
• W2015919732 countsByYear W20159197322019 @default.
• W2015919732 countsByYear W20159197322020 @default.
• W2015919732 countsByYear W20159197322021 @default.
• W2015919732 countsByYear W20159197322022 @default.
• W2015919732 countsByYear W20159197322023 @default.
• W2015919732 crossrefType "journal-article" @default.
• W2015919732 hasAuthorship W2015919732A5014280780 @default.
• W2015919732 hasAuthorship W2015919732A5046691342 @default.
• W2015919732 hasAuthorship W2015919732A5053380260 @default.
• W2015919732 hasAuthorship W2015919732A5053429712 @default.
• W2015919732 hasAuthorship W2015919732A5060570812 @default.
• W2015919732 hasAuthorship W2015919732A5070682945 @default.
• W2015919732 hasAuthorship W2015919732A5086893879 @default.
• W2015919732 hasConcept C126322002 @default.
• W2015919732 hasConcept C141071460 @default.
• W2015919732 hasConcept C164705383 @default.
• W2015919732 hasConcept C2776570981 @default.
• W2015919732 hasConcept C2780007028 @default.
• W2015919732 hasConcept C2780026749 @default.
• W2015919732 hasConcept C2780714102 @default.
• W2015919732 hasConcept C71924100 @default.
• W2015919732 hasConceptScore W2015919732C126322002 @default.
• W2015919732 hasConceptScore W2015919732C141071460 @default.
• W2015919732 hasConceptScore W2015919732C164705383 @default.
• W2015919732 hasConceptScore W2015919732C2776570981 @default.
• W2015919732 hasConceptScore W2015919732C2780007028 @default.
• W2015919732 hasConceptScore W2015919732C2780026749 @default.
• W2015919732 hasConceptScore W2015919732C2780714102 @default.
• W2015919732 hasConceptScore W2015919732C71924100 @default.
• W2015919732 hasIssue "6" @default.
• W2015919732 hasLocation W20159197321 @default.
• W2015919732 hasLocation W20159197322 @default.
• W2015919732 hasOpenAccess W2015919732 @default.
• W2015919732 hasPrimaryLocation W20159197321 @default.
• W2015919732 hasRelatedWork W2763459175 @default.
• W2015919732 hasRelatedWork W2883028617 @default.
• W2015919732 hasRelatedWork W2899605817 @default.
• W2015919732 hasRelatedWork W2900635594 @default.
• W2015919732 hasRelatedWork W2943962182 @default.
• W2015919732 hasRelatedWork W3095700562 @default.
• W2015919732 hasRelatedWork W33697106 @default.
• W2015919732 hasRelatedWork W4293018846 @default.
• W2015919732 hasRelatedWork W4309160260 @default.
• W2015919732 hasRelatedWork W4319939953 @default.
• W2015919732 hasVolume "28" @default.
• W2015919732 isParatext "false" @default.
• W2015919732 isRetracted "false" @default.
• W2015919732 magId "2015919732" @default.
• W2015919732 workType "article" @default.